<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nierengarten, Mary Beth</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">van't Hof, Arnoud W. J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Early Ticagrelor Improves ST Segment Resolution after PCI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-11</style></pages><abstract><style  face="normal" font="default" size="100%">A secondary prespecified substudy analysis of the Administration of Ticagrelor in the Cath Lab or in the Ambulance for New ST Elevation Myocardial Infarction to Open the Coronary Artery [ATLANTIC; NCT01347580] assessed whether prehospital administration of the direct-acting platelet P2Y12 receptor antagonist ticagrelor can improve coronary reperfusion and clinical outcomes in patients with STEMI. The results are discussed in this article</style></abstract><number><style face="normal" font="default" size="100%">42</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>